Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102221029-B1 |
titleOfInvention |
Treatment of cancer with dihydropyrazino-pyrazines |
abstract |
As a method for treating or preventing chronic lymphocytic leukemia, provided herein is a method comprising administering to a patient having chronic lymphocytic leukemia an effective amount of a dihydropyrazino-pyrazine compound. |
priorityDate |
2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |